{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:06:43Z","timestamp":1781215603662,"version":"3.54.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Liver disease remains a significant global health concern. In China, the number of patients with liver cirrhosis is estimated to reach 7 million. In addition to the high risk of death, cirrhosis leads to several severe complications. Patients with cirrhosis have significantly longer hospital stays and higher total hospital costs than those without cirrhosis. We aimed to investigate the predictors of readmission among patients with cirrhosis in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We conducted a retrospective study to evaluate adult patients with cirrhosis. Data on various sociodemographic, clinical, and hospitalization characteristics were collected. We defined the primary endpoint as the first liver-related readmission occurring within 30\u201390\u202fdays of initial hospitalization. Adult patients with cirrhosis admitted to our hospital between January 2009 and December 2022 were included. Differences between groups were analyzed using Student\u2019s t-test and chi-square test. Logistic and multiple linear regression analyses were performed to identify predictors associated with readmission and the length of the first hospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 1,285 patients were diagnosed with cirrhosis. Among these patients, 767 (59.7%) were males, and the mean age was 58.9\u202f\u00b1\u202f12.3\u202fyears. Seventy-two (5.6%) and 154 (12.0%) patients were readmitted within 30 and 90\u202fdays, respectively. Compared with those who were not readmitted, patients readmitted at 30-day and 90-day had a higher proportion of males, ascites, spontaneous bacterial peritonitis, electrolyte abnormalities, higher Child-Pugh\u2013Turcotte scores, longer initial hospital stays, and higher initial hospitalization costs. Logistic regression analysis indicated that hepatic encephalopathy, spontaneous bacterial peritonitis, diabetes, and ascites were predictors of 30- and 90-day readmission. Hypertension and spontaneous bacterial peritonitis were significant predictors of the length of the first hospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with cirrhosis presenting with hepatic encephalopathy, ascites, and spontaneous bacterial peritonitis may have a higher risk of rehospitalization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1417222","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:42:03Z","timestamp":1738305723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of patients with cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cgh.2016.07.020","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","volume":"15","author":"Stepanova","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.14309\/ajg.0000000000000257","article-title":"Cirrhosis as a comorbidity in conditions subject to the hospital readmissions reduction program","volume":"114","author":"Rosenblatt","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.21037\/atm-21-5258","article-title":"Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis","volume":"9","author":"Ebhohon","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.12788\/jhm.2967","article-title":"Hospital readmissions in patients with cirrhosis: a systematic review","volume":"13","author":"Orman","year":"2018","journal-title":"J Hosp Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2147\/TCRM.S203883","article-title":"Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients","volume":"15","author":"Dai","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2018.05.032","article-title":"Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004-2013","volume":"155","author":"Asrani","year":"2018","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2147\/cia.S444842","article-title":"Association between quality of life defined by euro Qol group 5 dimension and composite inferior outcome among inpatients with cirrhosis","volume":"19","author":"Hui","year":"2024","journal-title":"Clin Interv Aging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.21037\/atm-20-1762","article-title":"Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database","volume":"9","author":"Garg","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the health care burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"Allen","year":"2016","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.cgh.2016.04.009","article-title":"Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study","volume":"14","author":"Tapper","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/s0140-6736(21)01374-x","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hep.29408","article-title":"Impact of sustained Virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease","volume":"69","author":"Backus","year":"2018","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3350\/cmh.2020.0305","article-title":"Alcohol-related cirrhosis: the most challenging etiology of cirrhosis is more burdensome than ever","volume":"27","author":"Tonon","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2023.06.008","article-title":"China\u2019s fatty liver crisis: a looming public health emergency","volume":"165","author":"Yip","year":"2023","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","article-title":"The changing epidemiology of liver diseases in the Asia\u2013Pacific region","volume":"16","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3760\/cma.j.issn.1007-3418.2019.10.003","article-title":"Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cld.2019.07.001","article-title":"Hepatic encephalopathy challenges, burden, and diagnostic and therapeutic approach","volume":"23","author":"Yanny","year":"2019","journal-title":"Clin Liver Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cgh.2015.08.041","article-title":"A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis","volume":"14","author":"Tapper","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fmed.2023.1185182","article-title":"Neutrophil-to-lymphocyte ratio predicts 30-, 90-, and 180-day readmissions of patients with hepatic encephalopathy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1007\/s10620-021-07075-2","article-title":"Hepatic encephalopathy-related hospitalizations in cirrhosis: transition of care and closing the revolving door","volume":"67","author":"Frenette","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/apt.15749","article-title":"Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis","volume":"51","author":"Tapper","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cgh.2016.09.157","article-title":"Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures","volume":"15","author":"Bajaj","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/hep.28414","article-title":"The 3-month readmission rate remains unacceptably high in a large north American cohort of patients with cirrhosis","volume":"64","author":"Bajaj","year":"2016","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/MEG.0000000000001578","article-title":"Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors","volume":"32","author":"Abdel-Razik","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s40001-023-01126-2","article-title":"A risk score to predict 30-day hospital readmission rate in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Mousa","year":"2023","journal-title":"Eur J Med Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm10020262","article-title":"Association between liver cirrhosis and diabetes mellitus: a review on hepatic outcomes","volume":"10","author":"Coman","year":"2021","journal-title":"J Clin Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/liv.12770","article-title":"Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study","volume":"35","author":"Hoehn","year":"2015","journal-title":"Liver Int"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/hep4.1536","article-title":"Type 2 diabetes: a risk factor for hospital readmissions and mortality in Australian patients with cirrhosis","volume":"4","author":"Ahn","year":"2020","journal-title":"Hepatol Commun."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.numecd.2021.09.007","article-title":"Arterial hypertension - clinical trials update 2021","volume":"32","author":"Al Ghorani","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100892","DOI":"10.1016\/j.aohep.2022.100892","article-title":"Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease","volume":"28","author":"Liu","year":"2023","journal-title":"Ann Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"111860","DOI":"10.1016\/j.nut.2022.111860","article-title":"Malnutrition according to the global leadership initiative on malnutrition criteria is associated with in-hospital mortality and prolonged length of stay in patients with cirrhosis","volume":"105","author":"Yang","year":"2023","journal-title":"Nutrition"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/apt.12797","article-title":"Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States","volume":"40","author":"Singal","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/jgh.13255","article-title":"The benefit of paracentesis on hospitalized adults with cirrhosis and ascites","volume":"31","author":"Gaetano","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.soard.2022.03.011","article-title":"Outcomes of bariatric surgery in patients with obesity and compensated liver cirrhosis","volume":"18","author":"Khajeh","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3748\/wjg.v12.i5.678","article-title":"Liver cirrhosis and arterial hypertension","volume":"12","author":"Henriksen","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"H349","DOI":"10.1152\/ajpheart.00759.2016","article-title":"A pathogenic role of complement in arterial hypertension and hypertensive end organ damage","volume":"312","author":"Wenzel","year":"2017","journal-title":"Am J Phys Heart Circ Phys"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e95736","DOI":"10.1371\/journal.pone.0095736","article-title":"Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis","volume":"9","author":"Gomez","year":"2014","journal-title":"PLoS One"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1417222\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:42:09Z","timestamp":1738305729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1417222\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":49,"alternative-id":["10.3389\/fmed.2025.1417222"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1417222","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"1417222"}}